NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ('INBS' or the 'Company'), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the expansion of its customer network within the UK retail sector. This includes the adoption of INBS' Intelligent Fingerprinting Drug Screening System by three prominent UK retailers, among the largest and most recognized in the country..

2024年6月27日，纽约（环球通讯社）--Intelligent Bio Solutions Inc.（纳斯达克：INBS）（“INBS”或“公司”）是一家提供智能、快速、无创检测解决方案的医疗技术公司，今天宣布在英国零售业扩展其客户网络。这包括英国三家知名零售商采用了INBS的智能指纹药物筛选系统，这些零售商是英国最大和最受认可的零售商之一。。

The recently secured accounts employ over 55,000 individuals and include a British multinational retailer specializing in clothing, footwear, and accessories, a major UK-based kitchen retailer and manufacturer, and a British retail group specializing in sports and leisure clothing, footwear, and equipment.

。

Two retailers have transitioned from traditional third-party saliva testing to INBS's fingerprint drug screening technology. The switch to a more streamlined, hygienic, and less invasive testing methodology has addressed business and policy alignment issues and previous testing inefficiencies, facilitating smoother processes that enable larger testing volumes..

两家零售商已经从传统的第三方唾液检测转变为INBS的指纹药物筛查技术。转向更简化、更卫生、侵入性更小的测试方法解决了业务和政策一致性问题以及以前的测试效率低下问题，促进了更平滑的流程，从而实现了更大的测试量。。

Doug Heath, Vice president of Global Sales at INBS, commented, 'Our reach continues to extend into new sectors, indicating a demand for drug testing beyond just safety-critical industries. We're seeing more businesses taking proactive measures to ensure workplace safety and protect their reputation as responsible employers.

INBS全球销售副总裁道格·希思（DougHeath）评论道，“我们的业务范围继续扩展到新的领域，这表明药物检测的需求不仅仅限于安全关键行业。我们看到越来越多的企业采取积极措施，确保工作场所安全，保护其负责任雇主的声誉。

We are very pleased to welcome these prominent retail partners into our growing network.'.

我们非常高兴地欢迎这些杰出的零售合作伙伴加入我们不断增长的网络。”。

INBS' first-of-its-kind solution uses fingerprint sweat to provide a quick, hygienic, and easy-to-use method for drug testing, delivering results in just minutes. This unique approach tests for common drugs of abuse, including cocaine, cannabis, methamphetamine, and opiates.

INBS的首创解决方案使用指纹汗液为药物检测提供了一种快速，卫生且易于使用的方法，只需几分钟即可获得结果。这种独特的方法测试常见的滥用药物，包括可卡因、大麻、甲基苯丙胺和鸦片。

About Intelligent Bio Solutions Inc.

关于Intelligent Bio Solutions Inc。

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields.

Intelligent Bio Solutions Inc.（纳斯达克股票代码：INBS）是一家提供创新、快速、无创检测解决方案的医疗技术公司。该公司相信，其智能指纹药物筛选系统将通过指纹汗液分析彻底改变便携式测试，这在其他领域具有更广泛的应用潜力。

Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries.

该测试系统设计为一个卫生且具有成本效益的系统，用于筛查工作场所常见药物的近期使用情况，包括阿片类药物、可卡因、甲基苯丙胺和大麻。该技术在几秒钟内采集样本，在十分钟内取得结果，将成为安全关键行业雇主的宝贵工具。

Additionally, the Company's biosensor platform has the potential to test for various indications, ranging from immunological conditions to communicable diseases. The Company's current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners. .

此外，该公司的生物传感器平台有可能测试各种适应症，从免疫状况到传染病。该公司目前的客户群包括建筑、制造和工程、运输和物流公司、药物治疗机构和验尸官。。

For more information, visit: http://www.ibs.inc/

有关更多信息，请访问：‡http://www.ibs.inc/

Forward-Looking Statements:

前瞻性声明：

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.'s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others.

本新闻稿中的一些声明是1933年《证券法》第27A节、1934年《证券交易法》第21E节和1995年《私人证券诉讼改革法》所指的前瞻性声明，涉及风险和不确定性。本新闻稿中的前瞻性声明包括但不限于Intelligent Bio Solutions Inc.成功开发和商业化其药物和诊断测试的能力，从其合作伙伴关系和合作中实现商业利益，以及获得监管批准等。

Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc.

。智能生物解决方案公司。

has attempted to identify forward-looking statements by terminology, including 'believes,' 'estimates,' 'anticipates,' 'expects,' 'plans,' 'projects,' 'intends,' 'potential,' 'may,' 'could,' 'might,' 'will,' 'should,' 'approximately' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements.

试图通过术语识别前瞻性陈述，包括“相信”，“估计”，“预期”，“预期”，“计划”，“项目”，“意图”，“潜在”，“可能”，“可能”，“可能”，“可能”，“将会”，“应该”，“大约”或其他表达未来事件或结果不确定性的词语来识别这些前瞻性陈述。

These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions' public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events. .

这些声明只是预测，涉及已知和未知的风险、不确定性和其他因素，包括在Intelligent Bio Solutions向证券交易委员会提交的公开文件中。本版本中包含的任何前瞻性声明仅在发布之日起生效。Intelligent Bio Solutions没有义务更新本版本中包含的任何前瞻性声明，以反映其日期后发生的事件或情况，或反映意外事件的发生。。

Company Contact:

公司联系人：

Intelligent Bio Solutions Inc.

智能生物解决方案公司。

info@ibs.inc

info@ibs.inc

LinkedIn | Twitter

LinkedIn | Twitter

Investor & Media Contact:

投资者和媒体联系人：

Valter Pinto, Managing Director

总经理Valter Pinto

KCSA Strategic Communications

KCSA战略传播

PH: (212) 896-1254

电话：（212）896-1254

INBS@kcsa.com

INBS@kcsa.com